CCM
ALXN
Camber Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,175,000
| Closed | -$184M | – | 42 |
|
|
2020
Q4 | $184M | Sell |
1,175,000
-125,000
| -10% | -$19.5M | 6.44% | 4 |
|
|
2020
Q3 | $149M | Sell |
1,300,000
-100,000
| -7% | -$11.4M | 7.85% | 3 |
|
|
2020
Q2 | $157M | Sell |
1,400,000
-250,000
| -15% | -$28.1M | 8.99% | 3 |
|
|
2020
Q1 | $148M | Buy |
1,650,000
+775,000
| +89% | +$69.6M | 8.85% | 1 |
|
|
2019
Q4 | $94.6M | Buy |
875,000
+25,000
| +3% | +$2.7M | 4.82% | 6 |
|
|
2019
Q3 | $83.2M | Buy |
850,000
+450,000
| +113% | +$44.1M | 4.38% | 6 |
|
|
2019
Q2 | $52.4M | Sell |
400,000
-200,000
| -33% | -$26.2M | 2.44% | 15 |
|
|
2019
Q1 | $81.1M | Hold |
600,000
| – | – | 4.04% | 8 |
|
|
2018
Q4 | $58.4M | Buy |
+600,000
| New | +$58.4M | 2.77% | 13 |
|
|
2017
Q3 | – | Sell |
-200,000
| Closed | -$24.3M | – | 33 |
|
|
2017
Q2 | $24.3M | Buy |
+200,000
| New | +$24.3M | 1.18% | 21 |
|